<description>&lt;div&gt;
&lt;strong&gt;REFERENCE&lt;/strong&gt;&lt;br&gt;
Jeremias S. The Biosimilar Void: 90% of Biologics Coming Off Patent Will Lack Biosimilars. February 5, 2025. Accessed May 3, 2025. &lt;a href="https://www.centerforbiosimilars.com/view/the-biosimilar-void-90-of-biologics-coming-off-patent-will-lack-biosimilars"&gt;https://www.centerforbiosimilars.com/view/the-biosimilar-void-90-of-biologics-coming-off-patent-will-lack-biosimilars&lt;br&gt;
&lt;/a&gt;&lt;br&gt;

&lt;/div&gt;
</description>

Co-hosts Craig Burton, executive director of the Biosimilars Council, and Giuseppe Randazzo, senior vice president of sciences and regulatory affairs at the Association for Accessible Medicines (AAM), tackle the current biosimilar landscape and how the industry can emerge from the "biosimilar void."

This special vodcast series provided by The Center for Biosimilars® was developed in partnership with the AAM and Biosimilars Council.

Not So Different: A Podcast from The Center for Biosimilars

S7 Ep4: Escaping the Void: All Things Biosimilars With Craig & G

S7 Ep4: Escaping the Void: All Things Biosimilars With Craig & G

Description